Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Baxter

Showing results (51-60 of 81) with videos related to

Pageof 9
Sort By:
HIV Medicine|September 30, 2023
Rate of response to initial antiretroviral therapy according to level of pre-existing HIV-1 drug resistance detected by next-generation sequencing in the strategic timing of antiretroviral treatment (START) studyAlessandro Cozzi-Lepri, David Dunn, Anna Tostevin, et al.
The Journal of Biological Chemistry|November 26, 2004
The molecular mechanisms of coactivator utilization in ligand-dependent transactivation by the androgen receptorEva Estébanez-Perpiñá, Jamie M R Moore, Ellena Mar, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 16, 2008
Anti-obesity, anti-diabetic, and lipid lowering effects of the thyroid receptor beta subtype selective agonist KB-141Galina Bryzgalova, Suad Effendic, Akhtar Khan, et al.
The Journal of Biological Chemistry|July 2, 2011
A peroxisome proliferator-activated receptor gamma (PPARgamma)/PPARgamma coactivator 1beta autoregulatory loop in adipocyte mitochondrial functionTuo Deng, Douglas H Sieglaff, Aijun Zhang, et al.
The Journal of Biological Chemistry|October 7, 2004
Thyroxine-thyroid hormone receptor interactionsBen Sandler, Paul Webb, James W Apriletti, et al.
Science'S STKE : Signal Transduction Knowledge Environment|June 29, 2006
A high-throughput screening method to identify small molecule inhibitors of thyroid hormone receptor coactivator bindingLeggy A Arnold, Eva Estébanez-Perpiñá, Marie Togashi, et al.
AIDS (London, England)|May 11, 2002
Both baseline HIV-1 drug resistance and antiretroviral drug levels are associated with short-term virologic responses to salvage therapyJohn D Baxter, Thomas C Merigan, Deborah N Wentworth, et al.
HIV Clinical Trials|November 29, 2007
The Incidence of HIV drug resistance and its impact on progression of HIV disease among antiretroviral-naïve participants started on three different antiretroviral therapy strategiesMichael J Kozal, Katherine Huppler Hullsiek, Rodger D Macarthur, et al.
Renal Failure|October 7, 2004
Thyroid hormone transport is disturbed in erythrocytes from patients with chronic renal failure on hemodialysisMaria C S Rodrigues, Guilherme M Santos, C Aluízio da Silva, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 5, 2006
Disadvantages of structured treatment interruption persist in patients with multidrug-resistant HIV-1: final results of the CPCRA 064 studyJody Lawrence, Katherine Huppler Hullsiek, Lisa M Thackeray, et al.
Pageof 9

Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
HIV Medicine|September 30, 2023
Rate of response to initial antiretroviral therapy according to level of pre-existing HIV-1 drug resistance detected by next-generation sequencing in the strategic timing of antiretroviral treatment (START) studyAlessandro Cozzi-Lepri, David Dunn, Anna Tostevin, et al.
The Journal of Biological Chemistry|November 26, 2004
The molecular mechanisms of coactivator utilization in ligand-dependent transactivation by the androgen receptorEva Estébanez-Perpiñá, Jamie M R Moore, Ellena Mar, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 16, 2008
Anti-obesity, anti-diabetic, and lipid lowering effects of the thyroid receptor beta subtype selective agonist KB-141Galina Bryzgalova, Suad Effendic, Akhtar Khan, et al.
The Journal of Biological Chemistry|July 2, 2011
A peroxisome proliferator-activated receptor gamma (PPARgamma)/PPARgamma coactivator 1beta autoregulatory loop in adipocyte mitochondrial functionTuo Deng, Douglas H Sieglaff, Aijun Zhang, et al.
The Journal of Biological Chemistry|October 7, 2004
Thyroxine-thyroid hormone receptor interactionsBen Sandler, Paul Webb, James W Apriletti, et al.
Science'S STKE : Signal Transduction Knowledge Environment|June 29, 2006
A high-throughput screening method to identify small molecule inhibitors of thyroid hormone receptor coactivator bindingLeggy A Arnold, Eva Estébanez-Perpiñá, Marie Togashi, et al.
AIDS (London, England)|May 11, 2002
Both baseline HIV-1 drug resistance and antiretroviral drug levels are associated with short-term virologic responses to salvage therapyJohn D Baxter, Thomas C Merigan, Deborah N Wentworth, et al.
HIV Clinical Trials|November 29, 2007
The Incidence of HIV drug resistance and its impact on progression of HIV disease among antiretroviral-naïve participants started on three different antiretroviral therapy strategiesMichael J Kozal, Katherine Huppler Hullsiek, Rodger D Macarthur, et al.
Renal Failure|October 7, 2004
Thyroid hormone transport is disturbed in erythrocytes from patients with chronic renal failure on hemodialysisMaria C S Rodrigues, Guilherme M Santos, C Aluízio da Silva, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 5, 2006
Disadvantages of structured treatment interruption persist in patients with multidrug-resistant HIV-1: final results of the CPCRA 064 studyJody Lawrence, Katherine Huppler Hullsiek, Lisa M Thackeray, et al.
Pageof 9